Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998-2003

International Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 109-114

  Al Tawfiq, Jaffar A ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

Antibiotic resistance; Pseudomonas aeruginosa; Saudi Arabia; Surveillance

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD CULTURE; DRUG MONITORING; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SAUDI ARABIA; URINARY TRACT INFECTION; URINE CULTURE; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; INPATIENTS; MICROBIAL SENSITIVITY TESTS; OUTPATIENTS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; SAUDI ARABIA;

EID: 33847207164     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2005.11.004     Document Type: Article

References (25)

1. Carmeli Y., Troillet N., Karchmer A.W., and Samore M.H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159 (1999) 1127-1132
2. El Amari E.B., Chamot E., Auckenthaler R., Pechere J.C., and Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 33 (2001) 1859-1864
3. Jones R.N., Kirby J.T., Beach M.L., Biedenbach D.J., and Pfaller M.A. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 43 (2002) 239-243
4. Falherty J.P., and Weinstein R.A. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol 17 (1996) 236-248
5. Biedenbach D.J., Moet G.J., and Jones R.N. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50 (2004) 59-69
6. Jensen H.G., and Felix C. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group. Cornea 17 (1998) 79-87
7. Al-Jasser A.M., and Elkhizzi N.A. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa. Saudi Med J 25 (2004) 780-784
8. Ferraro M.J., and National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test: approved standard A6 and M7-A4. 8th ed. (1998), National Committee for Clinical Laboratory Standards, Wayne, PA
9. Raveh D., Rudensky B., Huerta M., Aviv Y., and Yinnon A.M. Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection. Eur J Clin Microbiol Infect Dis 22 (2003) 158-164
10. Raveh D., Rudensky B., Schlesinger Y., Benenson S., and Yinnon A.M. Susceptibility trends in bacteraemias: analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990-2000). J Hosp Infect 55 (2003) 196-203
11. Mutnick A.H., Rhomberg P.R., Sader H.S., and Jones R.N. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). J Antimicrob Chemother 53 (2004) 290-296
12. Rhomberg P.R., Jones R.N., Sader H.S., Fritsche T.R., and MYSTIC Programme Study Group. Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003). Diagn Microbiol Infect Dis 49 (2004) 273-281
13. Brown P.D., and Izundu A. Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Rev Panam Salud Publica 16 (2004) 125-130
14. Pitt T.L., Sparrow M., Warner M., and Stefanidou M. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 58 (2003) 794-796
15. Huang S.S., Labus B.J., Samuel M.C., Wan D.T., and Reingold A.L. Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999. Emerg Infect Dis 8 (2002) 195-201
16. Orrett F.A. Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources. J Natl Med Assoc 96 (2004) 1065-1069
17. Elouennass M., Foissaud V., Trueba F., Doghmi K., Malfuson J.V., Fagot T., et al. A 7-year survey of strains identified in blood cultures in a clinical hematology unit. Med Mal Infect 34 (2004) 62-69
18. Yaman A., Tasova Y., Kibar F., Inal A.S., Saltoglu N., Buyukcelik O., et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J 25 (2004) 1403-1409
19. Jung R., Fish D.N., Obritsch M.D., and MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect 57 (2004) 105-111
20. Blandino G., Marchese A., Ardito F., Fadda G., Fontana R., Lo Cascio G.L., et al. Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. Int J Antimicrob Agents 24 (2004) 515-518
21. Friedland I., Gallagher G., King T., and Woods G.L. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother 16 (2004) 437-441
22. Barsic B., Tambic A., Santini M., Klinar I., Kutlesa M., and Krajinovic V. Antibiotic resistance among nosocomial isolates in a Croatian intensive care unit-results of a twelve-year focal surveillance of nosocomial infections. J Chemother 16 (2004) 273-281
23. Harris A., Torres-Viera C., Venkataraman L., Degirolami P., Samore M., and Carmeli Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis 28 (1999) 1128-1133
24. Lang A., De Fina G., Meyer R., Aschbacher R., Zelger P., Paluselli P., et al. Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas. New Microbiol 24 (2001) 47-56
25. Shigemura K., Tanaka K., Okada H., Nakano Y., Kinoshita S., Gotoh A., et al. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan. Jpn J Infect Dis 58 (2005) 303-308